Panic Disorder
📧 Sign up to get email alerts when something new happens for Panic Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2009-01-27FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's supplemental application for venlafaxine hydrochloride, enabling marketing of a generic venlafaxine hydrochloride produc…
-
FDA approval · 2009-01-09FDA Approved: VENLAFAXINE — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a generic venlafaxine product under Heritage Pharmaceuticals’ original ANDA, for the treatment of major depressive disorder and…
-
FDA approval · 2009-01-09FDA Approved: ALPRAZOLAM — Original Application (Par Health USA, LLC)
The FDA approved ALPRAZOLAM from Par Health USA, LLC under ANDA078088. It represents a generic version of alprazolam for the treatment of an…
-
CLINICAL_TRIALS trial_result · 2008-12-08Clinical Trial Update: Trial of Seroquel SR for Alcohol Dependence and Comorbid Anxiety [Phase 4]
Phase 4 clinical trial update reporting the completion of a study evaluating Seroquel SR (quetiapine) for alcohol use disorder with comorbid…
-
CLINICAL_TRIALS trial_result · 2008-12-05Clinical Trial Update: Efficacy of Aerobic Exercise Added to Alprazolam in Panic Disorder Treatment [Phase 4]
Phase 4 trial evaluating aerobic exercise added to alprazolam for panic disorder; completed with posted results.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2008-10-31FDA Approved: PAROXETINE HYDROCHLORIDE — Supplemental Application (Apotex Corp)
FDA approved Apotex Corp's supplemental application for paroxetine hydrochloride (paroxetine HCl), confirming continued approval for the gen…
-
FDA approval · 2008-10-31FDA Approved: SERTRALINE HYDROCHLORIDE — Original Application (Rising Pharma Holdings, Inc.)
The FDA approved an original generic application for sertraline hydrochloride by Rising Pharma Holdings, Inc., allowing a generic version of…
-
FDA approval · 2008-10-22FDA Approved: FLUOXETINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for fluoxetine from Teva Pharmaceuticals USA, Inc., indicating a modification to the product's a…
-
CLINICAL_TRIALS trial_result · 2008-10-15Clinical Trial Update: Cognitive Behavioral Therapy in Panic Disorder
This entry reports the completion of a clinical trial evaluating cognitive behavioral therapy for panic disorder.
-
FDA approval · 2008-09-25FDA Approved: FLUOXETINE — Supplemental Application (QUALLENT PHARMACEUTICALS HEALTH LLC)
FDA approved a supplemental application for Fluoxetine hydrochloride from Quallent Pharmaceuticals Health LLC.
-
FDA approval · 2008-08-18FDA Approved: FLUOXETINE — Supplemental Application (Chartwell Governmental & Specialty RX, LLC)
FDA approved a supplemental application for fluoxetine submitted by Chartwell Governmental & Specialty RX, LLC.
-
FDA approval · 2008-08-18FDA Approved: FLUOXETINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental ANDA for Fluoxetine by Teva Pharmaceuticals USA, Inc., authorizing a generic version of fluoxetine. The action f…
-
CLINICAL_TRIALS research · 2008-08-15Clinical Trial Update: Treatment of Panic Disorder Among Individuals Consulting Emergency Departments for Non Cardiac Chest Pain [NA]
A clinical trial update describing treatment for panic disorder in individuals who visit emergency departments for non-cardiac chest pain; t…
-
FDA approval · 2008-08-13FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Venlafaxine hydrochloride from Teva Pharmaceuticals USA, Inc., a generic antidepressant.
-
FDA approval · 2008-07-16FDA Approved: SERTRALINE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approves a supplemental abbreviated new drug application (ANDA) for sertraline from Heritage Pharmaceuticals d/b/a Avet Pharmaceuticals …
-
FDA approval · 2008-07-02FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals, Inc.'s supplemental application for sertraline hydrochloride (generic sertraline), authorizing the a…
-
FDA approval · 2008-06-25FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for sertraline hydrochloride manufactured by Aurobindo Pharma Limited.
-
FDA approval · 2008-06-13FDA Approved: VENLAFAXINE HYDROCHLORIDE — Original Application (Dr. Reddy's Laboratories Limited)
FDA approved venlafaxine hydrochloride from Dr. Reddy's Laboratories Limited as an original application for a generic antidepressant product…
-
FDA approval · 2008-06-13FDA Approved: VENLAFAXINE — Original Application (BluePoint Laboratories)
FDA approved an original application for venlafaxine from BluePoint Laboratories (venlafaxine hydrochloride) under an Abbreviated New Drug A…
-
FDA approval · 2008-06-13FDA Approved: VENLAFAXINE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical's generic venlafaxine under an original ANDA (ANDA078627). The approval adds a generic option for treating m…
-
FDA approval · 2008-05-29FDA Approved: FLUOXETINE — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for a generic fluoxetine hydrochloride product from Lannett Company, Inc. under anANDA, confirming r…
-
FDA approval · 2008-05-23FDA Approved: EFFEXOR XR — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Effexor XR (venlafaxine hydrochloride) submitted by Viatris Specialty LLC.
-
FDA approval · 2008-05-20FDA Approved: PAROXETINE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for paroxetine hydrochloride/paroxetine from Zydus Lifesciences Limited, authorizing a generic parox…
-
FDA approval · 2008-05-20FDA Approved: VENLAFAXINE HYDROCHLORIDE — Original Application (Vertical Pharmaceuticals, LLC)
The FDA approved a generic venlafaxine hydrochloride product (Original Application) developed by Vertical Pharmaceuticals, LLC, for the trea…
-
FDA approval · 2008-04-17FDA Approved: FLUOXETINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for fluoxetine by Teva Pharmaceuticals USA, Inc. The approval updates the product labeling and/o…